• Vetiranary Medicine
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Boehringer Ingelheim Vetmedica unveils canine Lyme disease vaccine to veterinary channel

July 27, 2010

St. Joseph, Mo. -- Boehringer Ingelheim introduced its new canine Lyme disease vaccine to the veterinary market today during a live webcast.

St. Joseph, Mo.

-- Boehringer Ingelheim introduced its new canine Lyme disease vaccine to the veterinary market today during a live webcast.

The subcutaneous vaccine, Duramune Lyme, was recently approved by the United States Department of Agriculture for veterinary use as an aid in the prevention of Lyme disease.

Lorie North, senior brand manager of canine biologics for Boehringer Ingelheim Vetmedica, Inc., says the vaccine delivers multi-outer-surface-protein (Osp) protection and is proven safe and efficacious in multiple field studies. The vaccine achieved a 13-month duration of immunity, the company adds.

BI is making the vaccine available to veterinarians as a stand-alone or in combination to protect against parvovirus and leptospirosis. The vaccine is safe to use with Lyme-positive dogs, but administration of the vaccine is recommended to healthy dogs 9 weeks of age or older, North explains. The best tick prevention strategy includes annual vaccination, tick control on the animal and in the environment, and regular checks for ticks.

Advertisement

Matt Musselman, executive director of BI's companion animal/pet business, says the launch of Duramune Lyme is the first since the full integration of BI following the sale of certain Fort Dodge assets from Pfizer last year.

"We know the market is interested in this disease," Musselman says, "and we have a good strong product to protect pets."

In fact, the company is reintroducing this Lyme vaccine at a time when transmission rates are increasing. "Human Lyme (disease) cases have nearly doubled since 1995," he says. "When we look at human data, it gives a sentinel view of what is happening to our dog population."

Dr. Arnie Zislin, technical manager veterinarian with BI, explains that Duramune Lyme is a two-strain, whole-cell, multi-Osp Borrelia burgdorferi bacterin."(The vaccine) elicits a broad-spectrum antibody response against a wide variety of outer surface proteins, including A, B, C and more, in vaccinated dogs."

For more information, go to www.lymeinfo.com.

Related Content:

Breaking NewsParasitology
Unusual parasite strain kills 4 California sea otters
Unusual parasite strain kills 4 California sea otters
Traditional and holistic treatments for giardia
Traditional and holistic treatments for giardia
Guide offers help for navigating flea and tick season
Guide offers help for navigating flea and tick season

Advertisement

Latest News

Managing wounds in pet patients

Spectrum of care: protocols to support pet owners’ budgets

How to support women while still running a successful business

The Vets expands to Raleigh, NC

View More Latest News
Advertisement